| Literature DB >> 33193268 |
Yongsen Cao1, Huanbin Zhou1, Xueping Zhou1,2, Fangfang Li1.
Abstract
Plant diseases caused by invading plant viruses pose serious threats to agricultural production in the world, and the antiviral engineering initiated by molecular biotechnology has been an effective strategy to prevent and control plant viruses. Recent advances in clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated (Cas) system-mediated DNA or RNA editing/interference in plants make them very attractive tools applicable to the plant protection field. Here, we review the development of CRISPR/Cas systems and summarize their applications in controlling different plant viruses by targeting viral sequences or host susceptibility genes. We list some potential recessive resistance genes that can be utilized in antiviral breeding and emphasize the importance and promise of recessive resistance gene-based antiviral breeding to generate transgene-free plants without developmental defects. Finally, we discuss the challenges and opportunities for the application of CRISPR/Cas techniques in the prevention and control of plant viruses in the field.Entities:
Keywords: CRISPR; Cas proteins; antiviral engineering; plant virus; recessive resistance genes
Year: 2020 PMID: 33193268 PMCID: PMC7649272 DOI: 10.3389/fmicb.2020.593700
Source DB: PubMed Journal: Front Microbiol ISSN: 1664-302X Impact factor: 5.640
CRISPR/Cas system-mediated resistance to plant viruses by targeting the viral genome, host factors, and some potential recessive targets using genome editing systems.
| Viral replication region | TYLCCNV, TbCSV | ZFN | AOCl,AT4CLI,BAMI,CML38,CML39, | Geminiviruses |
| Viral IR region/replication region | TYLCCNV, TbCSV | TALEN | CPHSC70-1, CSNs, deltaCOP, GRAB2, HSC70, NSI, NsAK, PLP2, rgs-CaM, SCE1, SK4-I/SKK, SYTA1 | |
| Vil-Hl IR region/replication region | BeYDV. CLCuMuV | CRlSPR/SpCas9 | ||
| Viral IR region/replication region/CP | BCTV, CLC’uKoV, McMV, TYLCV | CRJSPR/SpCas9 | u-EXPA, bZIP60, CK2, cPGK, DBP1, DDXs, DnaJ-like proteins, eEFl A, eEFIB, eEF4E, eEF4G, eEF4G2, eEF(iso)4E, GRF6, IREI A, IRE1B, NBR1, PABPs, PCaPl, PVIPs, RAV2, RHs (RH8, RH9), Sec24a, SYTA1, SYP71 | Potyviruses |
| Viral genome region | BSCTV | C’RISPR/SpCas9 | l > ZIP60, CAT1, cPGK, eEFIB, EXA1 | Potexviruses |
| Viral long IR region/MP/CP/replication region | WDV, BSV | CRlSPR/SpCas9 | ARL8a/8b, eEFIA, SYTA1, TOM1, TOM2A, TOM3 | Tobamoviruses |
| Viral CP | CaMV | CRISPR/SpCas9 | Chl-PCK, eEFIA | BaMV |
| Viral coding ORF/non-coding region/3′ UTR | TMV, CMV | CRISPR/FnCas9 | PDIL5-1 | BaYMV, BaMMV |
| Viral HC-Pro/CP/GFP region | TuMV (TuMV-GFP) | CRISPR/LshCasl3a, Rfi(Casl3d | FDH, CRT3, HAT1, HAT2, HAT3, VPS41 | CMV |
| Viral coding ORF | TMV, SRBSDV | (RISPR LshCa.sl3a | PDLP1/PDLP2/PDLP3 | GFLV.CaMV |
| Viral NIh/P3/CI/CP region | PVY | C’RISPR/LshCasl3a | EXAI | LoLV |
| Host gene elF4E | CVYV, ZYMV, PRSV-W, TuMV | CRISPR’SpCas9 | eEFIA, ESCRT, GAPDH, RAB5, SYPK1 | TBSV |
| Host gene elF4E | C1YVV | CRISPR/nCaaS- cytidine deaminase | SYTA1 | TVCV |
| Host gene el F4G | RTSV | CRISPR/SpCas9 | CPR5 | RYMV |
| Host gene elF(iso)4E | TuMV | CRISPR/SpCas9 | RIM1.SAMS1 | RDV |
| Host gene nCBP-l/nCBP-2 | CBSV | CRISPR/SpCas9 | RHD3 | TSWV |
FIGURE 1Schematic representation of class 2 CRISPR/Cas systems to confer resistance to plant viruses. After plant viruses enter into plant cells, the viral genome is uncoated and transcribed, or translated with the help of host factors. Plant viruses then multiply their genome in the nucleus or in the cytoplasm. The viral genome DNA or RNA can be targeted, destroyed, or interfered with by CRISPR/Cas9 or CRISPR/Cas13 (or FnCas9) systems in the nucleus or in the cytoplasm, respectively, which inhibits viral infection. In addition, the mutation or deficiency in host susceptibility factors edited by the CRISPR/Cas9 system also perturbs viral infection. However, some new viral variants might be generated as by-products when CRISPR/Cas systems edit the viral genome, which might drive the risk of viral evolution.